| Literature DB >> 35356140 |
Bo-Ae Lee1,2, Young-Joo Kim3.
Abstract
This study was conducted to investigate the effect of regular endurance exercises on the management of cardiovascular health in middle-aged men. The following conclusions were drawn as the result of comparatively analyzing middle-aged men who regularly performed triathlon and cycling exercises for more than 5 years. The effect of regular endurance exercises on cardiovascular health management in middle-aged men was found to be relatively positive. However, prolonged endurance exercises can cause cardiovascular disease which can adversely affect the cardiac function, and to date, no defining limit is known about the amount of exercise that improves the cardiovascular function while reducing the cardiovascular events. Therefore, aiming for exercises at moderate intensity that befit the individual's fitness level as well as conducting regular examinations to predict and manage the risk of sudden cardiac death from exercising were considered as the more effective method of cardiovascular health management.Entities:
Keywords: Cardiovascular disease; Cycling; Endurance exercise; Health; Middle-aged man; Triathlon
Year: 2022 PMID: 35356140 PMCID: PMC8934609 DOI: 10.12965/jer.2142674.337
Source DB: PubMed Journal: J Exerc Rehabil ISSN: 2288-176X
General characteristics of the subjects
| Characteristic | Triathlon group | Cycle group |
|---|---|---|
| Age (yr) | 51.50±6.04 | 49.75±5.94 |
| Weight (kg) | 69.03±5.02 | 63.63±6.22 |
| Height (cm) | 170.98±3.65 | 168.32±3.20 |
| Body mass index (kg/m2) | 23.70±1.38 | 23.40±1.26 |
| Body fat percentage (%) | 13.30±4.92 | 14.76±4.42 |
Values are presented as mean±standard deviation.
Between-group differences in cardiovascular factor analysis
| Variable | Group | Mean±SD | ||
|---|---|---|---|---|
| RHR (beats/min) | Triathlon | 64.12±6.28 | −1.148 | 0.162 |
| Cycle | 58.62±8.38 | |||
|
| ||||
| MHR (beats/min) | Triathlon | 181.75±6.13 | −2.207 | 0.051 |
| Cycle | 171.37±11.79 | |||
|
| ||||
| RSBP (mmHg) | Triathlon | 117.75±13.11 | 1.453 | 0.174 |
| Cycle | 125.50±7.46 | |||
|
| ||||
| RDBP (mmHg) | Triathlon | 75.37±7.11 | −0.325 | 0.750 |
| Cycle | 74.00±9.62 | |||
|
| ||||
| MSBP (mmHg) | Triathlon | 213.12±19.98 | 0.984 | 0.342 |
| Cycle | 223.00±20.16 | |||
|
| ||||
| MDBP (mmHg) | Triathlon | 74.25±8.49 | 1.197 | 0.254 |
| Cycle | 80.87±13.14 | |||
|
| ||||
| VO2max (mLO2/kg/min) | Triathlon | 50.48±3.74 | −0.155 | 0.879 |
| Cycle | 50.14±4.93 | |||
|
| ||||
| ED (sec) | Triathlon | 913.50±83.37 | 1.094 | 0.294 |
| Cycle | 859.87±110.77 | |||
SD, standard deviation; RHR, resting heart rate; MHR, maximal heart rate; RSBP, resting systolic blood pressure; RDBP, resting diastolic blood pressure; MSBP, maximal systolic blood pressure; MDBP, maximal diastolic blood pressure; VO max, maximal oxygen uptake; ED, exercise duration.
Structural analysis of intergroup differences: heart
| Variable | Group | Mean±SD | ||
|---|---|---|---|---|
| LVIDd (cm) | Triathlon | 4.91±0.38 | 0.143 | 0.888 |
| Cycle | 4.93±0.30 | |||
|
| ||||
| LVIDs (cm) | Triathlon | 3.07±0.35 | −0.074 | 0.942 |
| Cycle | 3.06±0.32 | |||
|
| ||||
| IVSd (cm) | Triathlon | 0.97±0.07 | −0.809 | 0.432 |
| Cycle | 0.93±0.07 | |||
|
| ||||
| LVPWd (cm) | Triathlon | 0.96±0.05 | −1.686 | 0.123 |
| Cycle | 0.88±0.11 | |||
|
| ||||
| LVEDV (mL) | Triathlon | 116.77±26.18 | 0.060 | 0.953 |
| Cycle | 117.43±17.08 | |||
|
| ||||
| LVM (g) | Triathlon | 173.62±22.62 | −1.178 | 0.259 |
| Cycle | 161.50±18.31 | |||
|
| ||||
| LVM index (g/m2) | Triathlon | 96.96±6.99 | −1.289 | 0.224 |
| Cycle | 90.12±12.73 | |||
SD, standard deviation; LVIDd, left ventricular inter dimension at end-diastole; LVIDs, left ventricular inter dimension at end-systole; IVSd: interventricular septal thickness end-diastole; LVPWd, left ventricular posterior wall thickness at end-diastole; LVEDV, left ventricular end-diastolic volume; LVM, left ventricular mass.
Result of comparison of cardiac functions
| Variable | Group | Mean±SD | ||
|---|---|---|---|---|
| LVSV (mL) | Triathlon | 77.35±19.49 | 0.181 | 0.860 |
| Cycle | 78.77±10.87 | |||
|
| ||||
| LVCO (mL/min) | Triathlon | 4.49±0.98 | 0.417 | 0.683 |
| Cycle | 4.68±0.78 | |||
|
| ||||
| LVEF (%) | Triathlon | 66.05±6.51 | 0.475 | 0.643 |
| Cycle | 67.45±5.21 | |||
|
| ||||
| E-velocity (m/sec) | Triathlon | 0.56±0.08 | 2.842 | 0.018[ |
| Cycle | 0.76±0.17 | |||
|
| ||||
| A-velocity (m/sec) | Triathlon | 0.49±0.11 | 2.232 | 0.043[ |
| Cycle | 0.61±0.09 | |||
|
| ||||
| E/A ratio (%) | Triathlon | 1.15±0.14 | 0.837 | 0.423 |
| Cycle | 1.26±0.34 | |||
|
| ||||
| DT (m/sec) | Triathlon | 0.23±0.03 | −3.146 | 0.007[ |
| Cycle | 0.17±0.03 | |||
|
| ||||
| E′-velocity (m/sec) | Triathlon | 9.12±1.12 | 1.112 | 0.295 |
| Cycle | 10.37±2.97 | |||
|
| ||||
| A′-velocity (m/sec) | Triathlon | 8.12±1.35 | 1.880 | 0.081 |
| Cycle | 9.37±1.30 | |||
|
| ||||
| E′/A′ ratio (%) | Triathlon | 2.33±3.34 | −1.008 | 0.346 |
| Cycle | 1.13±0.34 | |||
|
| ||||
| E/E′ ratio (%) | Triathlon | 5.71±1.89 | 2.238 | 0.045[ |
| Cycle | 7.49±1.20 | |||
SD, standard deviation; LVSV, left ventricular stroke volume; LVCO, left ventricular cardiac output; LVEF, left ventricular ejection fraction; E-velocity, peak mitral velocity early filling; A-velocity, peak atrial velocity early filling; E/A ratio, ratio of peak mitral early and atrial filling velocities; DT, deceleration time; E′-velocity, early diastolic annulus velocity; A′-velocity, late diastolic annulus velocity; E′/A′ ratio, ratio of early diastolic annulus velocity and late diastolic annulus velocity; E/E′ ratio, ratio of peak mitral early and early diastolic annulus velocity.
P<0.05.
P<0.01.